Mr. Antonia is a Director at the Center for Cancer Immunotherapy at Duke University.
Scott Antonia, MD, PhD
Clinical Advisor
Mr. Antonia is a Director at the Center for Cancer Immunotherapy at Duke University.
Tanios Bekaii-Saab, MD
Clinical Advisor
Mr. Antonia is a Director at the Center for Cancer Immunotherapy at Duke University.
Tanios Bekaii-Saab, MD
Clinical Advisor
Mr. Antonia is a Director at the Center for Cancer Immunotherapy at Duke University.
Scott Kopetz, MD, PhD, FACP
Clinical Advisor
Dr. Kopetz is a Professor in the Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center. He is a physician-scientist who enjoys the intellectual challenges of the lab, the emotional engagement of the clinic and has the motivation to bridge the two.
Scott Kopetz, MD, PhD, FACP
Clinical Advisor
Dr. Kopetz is a Professor in the Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center. He is a physician-scientist who enjoys the intellectual challenges of the lab, the emotional engagement of the clinic and has the motivation to bridge the two.
Gilberto de Lima Lopes Jr, MD, MBA, FAMS
Clinical Advisor
Dr. de Lima Lopes is Chair of Oncology and Associate Professor of Clinical Medicine at the University of Miami and works on developing new drugs to treat cancer as well as designing, leading and participating in Phase I through IV clinical trials. He has helped bring novel cancer therapies into the clinic. He is also a leader in the area known as Global Oncology and is the Editor for the Journal of Global Precision Oncology.
Gilberto de Lima Lopes Jr, MD, MBA, FAMS
Clinical Advisor
Dr. de Lima Lopes is Chair of Oncology and Associate Professor of Clinical Medicine at the University of Miami and works on developing new drugs to treat cancer as well as designing, leading and participating in Phase I through IV clinical trials. He has helped bring novel cancer therapies into the clinic. He is also a leader in the area known as Global Oncology and is the Editor for the Journal of Global Precision Oncology.
Mike Varney, PhD
Science Advisor
Dr. Varney is a consultant for the pharmaceutical and biotech community. He focuses on Drug Discovery, Drug Development and Strategic advising.
Mike Varney, PhD
Science Advisor
Dr. Varney is a consultant for the pharmaceutical and biotech community. He focuses on Drug Discovery, Drug Development and Strategic advising.
William A. Hawkins
Business Advisor
Mr. Hawkins is former Chairman and CEO of Medtronic as well as a current and active board member on public, private and not-for-profit boards. He is a Senior Advisor to EW Healthcare partners and Vice Chair of the Duke Board of Trustees and Chair of the Board of the Duke University Health System.
William A. Hawkins
Business Advisor
Mr. Hawkins is former Chairman and CEO of Medtronic as well as a current and active board member on public, private and not-for-profit boards. He is a Senior Advisor to EW Healthcare partners and Vice Chair of the Duke Board of Trustees and Chair of the Board of the Duke University Health System.
David C. Heimbrook, PhD
Business Advisor
Dr. Heimbrook received his BA degree from Duke University and his PhD in Biochemistry from Yale University. He brings over 30 years experience in cancer research and drug discovery, and recently retired from his position leading Frederick National Laboratory for Cancer Research, a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI).
David C. Heimbrook, PhD
Business Advisor
Dr. Heimbrook received his BA degree from Duke University and his PhD in Biochemistry from Yale University. He brings over 30 years experience in cancer research and drug discovery, and recently retired from his position leading Frederick National Laboratory for Cancer Research, a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI).
